The Code of Misconduct

Scientific misconduct is more than falsification, fabrication, and plagiarism – and harder to identify.  In 1998, Andrew Wakefield, MD, and co-authors investigated a cohort of 12 children with chronic digestive problems who were experiencing symptoms...

Online Exclusives

Leading Cancer Researcher Failed to Disclose Industry Funding

An investigation by The New York Times and ProPublica has found that José Baselga, MD, PhD, chief medical officer at Memorial Sloan Kettering Cancer...

AACR Releases Cancer Progress Report

Bipartisan commitment to investing in biomedical science has led to innovations in cancer research, according to the American Association for Cancer Research’s (AACR’s) recently...

News

From the Blood Journals

WIB_icon

Mapping Silent Cerebral Infarcts in Children With Sickle Cell Anemia

Children with sickle cell anemia (SCA) are at risk of developing cerebral ischemia, including a high prevalence of silent cerebral infarcts (SCI), which can...

Can Cytarabine Prevent Progression to Myeloid Leukemia in Children With Down...

In pediatric patients with Down syndrome (DS) and transient myeloproliferative disorder (TMD), treatment with low-dose cytarabine lowered early mortality risk, compared with historical controls,...

Multimedia

Pulling Back the Curtain: Angela Thomas, OBE, PhD

Hear more from our interview with Dr. Thomas, where she talks about "converting" trainees to pediatric hematology and offers career advice for early-career hematologists.

Pulling Back the Curtain: Allison Rosenthal, DO

Hear more from our interview with Dr. Rosenthal, where she talks about the best career advice she's ever received and the best (and worst) parts of...
video

Expanding Acalabrutinib to Waldenström Macroglobulinemia

Roger Owen, MRCP, MRCPath, MD, presents phase II data of the selective Bruton tyrosine kinase inhibitor, which showed “exceptional response rates” in both treatment-naïve...
video

Weekly Carfilzomib Dosing Superior to Twice-Weekly Dosing

James Berenson, MD, discusses results from a trial evaluating less-frequent dosing of carfilzomib for patients with myeloma. Once-weekly dosing was superior, but the mechanisms...

On Location

From ASH Meeting on Hematologic Malignancies: Treating a Young Patient With Newly Diagnosed ALL

During their presentations, MHM speakers will be asking the audience how they would respond to...

From ASH Meeting on Hematologic Malignancies: Treating Patients With AML With Mutations and Minimal Residual Disease

During their presentations, MHM speakers will be asking the audience how they would respond to...

From ASH Meeting on Hematologic Malignancies: Treating “Problematic” Cases of Polycythemia Vera

During their presentations, MHM speakers will be asking the audience how they would respond to...

APR-246 Plus Azacitidine Is Associated With High Response Rates in MDS and AML

In a small phase IB/II trial presented at the 23rd Congress of the European Hematology...

Umbralisib Demonstrates Safety, Efficacy for Patients With Kinase Inhibitor–Intolerant CLL

According to a report presented at the 23rd Congress of the European Hematology Association, the...

Tagraxofusp: A New Option for Blastic Plasmacytoid Dendritic Cell Neoplasm?

Treatment with tagraxofusp, an anti-CD123 targeted agent previously known as SL-401, appeared to be safe...

Latest Headlines

Advertisement

ASH Directions

Start Planning Now for the 60th ASH Annual Meeting and Exposition, and more

Start Planning Now for the 60th ASH Annual Meeting and Exposition  The preliminary program for the 2018 ASH annual meeting is now available online. The...

Mehdi Hamadani Named Editor of ASH News Daily 2018, and more

Mehdi Hamadani Named Editor of ASH News Daily 2018  Mehdi Hamadani, MD, has been named the 2018 Editor-in- Chief of ASH News Daily, the official...

Sign up for our
eNewsletter!

NIH Awards $24 Million to UT Health San Antonio, and more

Remembering Michael C. Lill (1959-2018)  Michael C. Lill, MD, passed away on June 19, 2018, after a long battle with cancer. Dr. Lill was born...

Fred Hutch Scientists Receive $20 Million for Leukemia Projects, and more

Remembering Alan Rabson (1926 – 2018)Alan Rabson, MD, a long-time leader at the National Cancer Institute (NCI), passed away on July 4, 2018, at...

American Cancer Society Awards $2.6 Million for Immunotherapy Research, and more

Remembering Past ASH President George Stamatoyannopoulos (1934 - 2018) George Stamatoyannopoulos, MD, DrSci, a professor of medical genetics at the University of Washington who pioneered...

The Code of Misconduct

Scientific misconduct is more than falsification, fabrication, and plagiarism – and harder to identify.  In 1998, Andrew Wakefield, MD, and co-authors investigated a cohort of...

Ad Nauseam

With new forays into sponsored content, pharmaceutical companies are rewriting the script for direct-to-consumer advertising.  When U.S. consumers settle in to watch their favorite TV...

MOC Machinations

The changing landscape of MOC Knowledge Check-Ins and how the American Society of Hematology continues pursuing a pragmatic approach to the MOC process.  The past...